Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Weir to buy Brazilian mining software provider Fast2Mine

(Sharecast News) - Weir said on Tuesday that it has agreed to by Brazilian mining software provider Fast2Mine for an undisclosed sum.

The engineer said the acquisition complements Micromine's existing suite of mine planning and mine control software and has no impact on its full-year guidance as of 31 July.

Fast2Mine's technology helps miners with material management, mine optimisation, short-interval control, fleet management, and select asset health diagnostics.

Weir said the company's "robust" platform is offered as a SaaS solution comprising of four modules designed around a modern, web-native interface "that prioritises ease of use while delivering advanced reporting functionality".

The platform currently services 84 mines across multiple commodities and countries, such as Brazil, Chile, Argentina, Mexico, Guyana, and Liberia.

Chief executive Jon Stanton said: "The acquisition of Fast2Mine will accelerate our expansion into the South American mining software market, providing a strong and immediate presence in Brazil, home to some of the world's largest mineral deposits.

"Fast2Mine's software platform is a highly complementary addition to Weir's mining software suite, including meaningful synergies with Micrormine's Alastri open pit mine planning solution and adjacency with Micromine's Pitram underground fleet management solution. We are looking forward to welcoming Fast2Mine to Weir and are excited by the opportunity to further accelerate our vision for digitally enabled mine optimisation."

At 1310 BST, the shares were up 0.8% at 2,686.0p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.